Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.

BACKGROUND Septic shock remains a significant health concern worldwide, and despite progress in understanding the physiological and molecular basis of septic shock, the high mortality rate of patients with septic shock remains unchanged. We recently identified a common polymorphism in toll-like receptor 4 (TLR4) that is associated with hyporesponsiveness to inhaled endotoxin or lipopolysaccharide in humans. METHODS Since TLR4 is a major receptor for lipopolysaccharide in mammals and gram-negative bacteria are the prevalent pathogen associated with septic shock, we investigated whether these specific TLR4 alleles are associated with a predisposition to a more severe disease outcome for patients with septic shock. We genotyped 91 patients with septic shock as well as 73 healthy blood donor controls for the presence of the TLR4 Asp299Gly and TLR4 Thr399Ile mutations. RESULTS We found the TLR4 Asp299Gly allele exclusively in patients with septic shock (P =.05). Furthermore, patients with septic shock with the TLR4 Asp299Gly/Thr399Ile alleles had a higher prevalence of gram-negative infections. CONCLUSION Mutations in the TLR4 receptor may predispose people to develop septic shock with gram-negative microorganisms.

[1]  B. Beutler,et al.  Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. , 2000, European cytokine network.

[2]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[3]  Paterson Rl,et al.  Sepsis and the systemic inflammatory response syndrome. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[4]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[5]  J. Dhainaut,et al.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. , 1999, JAMA.

[6]  D. Schwartz,et al.  Variable airway responsiveness to inhaled lipopolysaccharide. , 1999, American journal of respiratory and critical care medicine.

[7]  K. Tracey,et al.  Tolerance to shock: an exploration of mechanism. , 1999, Annals of surgery.

[8]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[9]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[10]  K. Tracey,et al.  From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? , 1999, Shock.

[11]  S. Wright.  Toll, A New Piece in the Puzzle of Innate Immunity , 1999, The Journal of experimental medicine.

[12]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[13]  D. DeFranco,et al.  Molecular chaperones and subcellular trafficking of steroid receptors 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  Elsayed A. Elsayed,et al.  A Methodology for the Health Sciences , 1997 .

[15]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[16]  D. Schwartz,et al.  The kinetics of grain dust-induced inflammation of the lower respiratory tract. , 1997, American journal of respiratory and critical care medicine.

[17]  R. Bone.  Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). Gulliver in Laputa. , 1995, JAMA.

[18]  Lloyd D. Fisher,et al.  2. Biostatistics: A Methodology for the Health Sciences , 1994 .

[19]  G. Fantuzzi,et al.  Differential regulation of cytokine production in lipopolysaccharide tolerance in mice , 1993, Infection and immunity.

[20]  L. Fisher,et al.  Biostatistics: A Methodology for the Health Sciences , 1993 .

[21]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[22]  R. Bone,et al.  Gram-negative sepsis. Background, clinical features, and intervention. , 1991, Chest.

[23]  W. Knaus,et al.  Multiple systems organ failure: epidemiology and prognosis. , 1989, Critical care clinics.

[24]  L. Hagberg,et al.  Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections. , 1985, Journal of immunology.